Table 1.
Characteristics of study participants
| ID | Age (years) |
Gendera | CD4 (cells/μL) |
CD8 (cells/μL) |
CD4/CD8 Ratio |
Viral Load (HIV RNA copies/mL) |
Time to ART initiation (years) |
Estimated time of infection (years)b |
Time on ART (years) |
|---|---|---|---|---|---|---|---|---|---|
| ST114 | 40 | M | 1145 | 1410 | 0.8 | < 20 | 0.4 | 6.2 | 5.9 |
| ST116 | 47 | M | 772 | 921 | 0.8 | < 20 | 2.6 | 9.4 | 6.8 |
| ST120 | 48 | M | 686 | 792 | 0.9 | < 20 | 6.0 | 15.4 | 9.4 |
| ST135 | 32 | M | 734 | 703 | 1.0 | < 20 | 4.9 | 7.4 | 2.5 |
| ST140 | 36 | M | 1102 | 875 | 1.3 | < 20 | N.Ac | N.A | N.A |
| ST142 | 46 | F | 1030 | 1192 | 0.9 | < 20 | N.A | 18.6 | N.A |
| ST144 | 56 | M | 715 | 709 | 1.0 | 140 | N.A | 27.6 | N.A |
| ST145 | 46 | M | 1897 | 830 | 2.3 | < 20 | N.A | 19.7 | N.A |
| ST105C | 60 | M | 677 | 788 | 0.9 | < 20 | N.A | N.A | N.A |
| ST137B | 41 | M | 267 | 518 | 0.5 | < 20 | N.A | N.A | N.A |
| CHO-17 | 48 | M | 662 | 658 | 1.0 | ˂ 40 | 0.2 | 16.9 | 16.7 |
| CHO-18 | 36 | M | 882 | 1177 | 0.7 | ˂ 40 | 4.7 | 13.8 | 9.1 |
| CHO-20 | 55 | M | 847 | 613 | 1.4 | ˂ 40 | 15.1 | 29.3 | 14.1 |
| CHO-25 | 60 | M | 803 | 422 | 1.9 | ˂ 40 | 4.8 | 25.1 | 20.4 |
| CHO-32 | 47 | M | 625 | 511 | 1.2 | ˂ 40 | 0.3 | 15.1 | 14.8 |
| CHO-34 | 36 | M | 471 | 322 | 1.5 | ˂ 40 | 7.8 | 12.0 | 4.2 |
| CHO-37 | 58 | M | 602 | 349 | 1.7 | < 20 | 1.0 | 9.2 | 7.9 |
| CHO-38 | 57 | M | 1173 | 1209 | 1.0 | < 20 | 0.6 | 20.7 | 20.1 |
| Median | 47 | - | 753 | 749 | 1.0 | - | 3.7 | 15.4 | 9.3 |
| IQ range | [40–56] | - | [666–993] | [542–910] | [0.9–1.4] | - | [0.5–5.2] | [10.7–20.2] | [6.5–15.3] |
a
F = female, M = male
b
Time of infection was calculated from the date of diagnosis
c
N.A = not available